This compound is a pharmaceutical intermediate used in the manufacturing of elagolix, featuring a complex molecular structure containing multiple aromatic rings, ether groups, and halogens.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 830346-51-5
Elagolix
GnRH antagonist active pharmaceutical ingredient
1,1-Dimethylethyl N-[(1R)-2-[5-bromo-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
Elagolix sodium
gonadotropin-releasing hormone antagonist
Benzoic acid, 2,4-difluoro-, ion(1-)
Pharmaceutical intermediate
3,5-Dimethylisoxazole-4-boronic acid pinacol ester
pharmaceutical intermediate
2-(3-(Carboxymethyl)-4-(phenylthio)phenyl)propanoic acid
Zatoprofen intermediate anti-inflammatory
(1R,5S)-8-Benzyl-8-azabicyclo(3.2.1)octan-3-one hydrochloride
pharmaceutical intermediate
Ethyl 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl)-1-phenylethyl)amino)butanoate
Elagolix intermediate
tert-butyl N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]carbamate
UOUIRPGFUIEVPG-VWLOTQADSA-N
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NC(=O)OC(C)(C)C)C4=C(C(=CC=C4)OC)F